Product Name: Human c-Met / HGFR Antibody (Telisotuzumab, Research Use)
Catalog Number: NBR-0022
Target Name: c-Met / HGFR
Trade Name: Telisotuzumab
Antibody Drug Description: Telisotuzumab vedotin (ABBV-399) is an antibody drug conjugate (ADC) targeting cMet that is being investigated to treat non-small cell lung cancer. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: c-Met / HGFR
Synonyms: DFNB97; RCCP2; HGFR
Target Description: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand.
Ensembl: ENSG00000105976
Uniprot: P08581